PDS Biotechnology Corporation closed a $6,000,000 promissory note and a warrant to purchase 2,158,274 shares at $1.1824 per share with YA II PN, LTD. The company also entered into a $50,000,000 at-the-market equity offering program with Yorkville Securities, LLC and B. Riley Securities, Inc. to provide working capital. PDS Biotechnology is a biotechnology company focused on developing immunotherapy treatments.
